JoVE Logo
Authors
Contact Us

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We provide a generalized protocol based on a microfluidic bioprinting strategy for engineering a microfibrous vascular bed, where a secondary cell type could be further seeded into the interstitial space of this microfibrous structure to generate vascularized tissues and organoids.

Abstract

Engineering vascularized tissue constructs and organoids has been historically challenging. Here we describe a novel method based on microfluidic bioprinting to generate a scaffold with multilayer interlacing hydrogel microfibers. To achieve smooth bioprinting, a core-sheath microfluidic printhead containing a composite bioink formulation extruded from the core flow and the crosslinking solution carried by the sheath flow, was designed and fitted onto the bioprinter. By blending gelatin methacryloyl (GelMA) with alginate, a polysaccharide that undergoes instantaneous ionic crosslinking in the presence of select divalent ions, followed by a secondary photocrosslinking of the GelMA component to achieve permanent stabilization, a microfibrous scaffold could be obtained using this bioprinting strategy. Importantly, the endothelial cells encapsulated inside the bioprinted microfibers can form the lumen-like structures resembling the vasculature over the course of culture for 16 days. The endothelialized microfibrous scaffold may be further used as a vascular bed to construct a vascularized tissue through subsequent seeding of the secondary cell type into the interstitial space of the microfibers. Microfluidic bioprinting provides a generalized strategy in convenient engineering of vascularized tissues at high fidelity.

Introduction

Tissue engineering targets to generate functional tissue substitutes that can be used to replace, restore, or augment those injured or diseased in the human body1,2,3,4, often through a combination of desired cell types, bioactive molecules5,6, and biomaterials7,8,9,10. More recently, tissue engineering technologies have also been increasingly adopted to generate in vitro tissue and organ models that mimic the important functions of their in vivo counterparts, for applications such as drug development, in replacement of the conventional over-simplified planar cell cultures11,12,13,14,15,16,17,18,19. In both situations, the ability to recapitulate the complex microarchitecture and hierarchical structure of the human tissues is critical in enabling functionality of the engineered tissues10, and in particular, ways to integrate a vascular network into the engineered tissues are of demand since vascularization presents one of the greatest challenges to the field20,21,22,23.

To date, a variety of approaches have been developed in this regard in an attempt to build blood vessel structures into engineered tissue constructs with various degrees of success8. For example, self-assembly of endothelial cells allows for generation of microvascular networks24; delivery of angiogenic growth factors induces sustained neovascularization25,26; use of vascular progenitor cells and pericytes facilitates endothelial cell growth and assembly24,27; designing scaffold properties enables precise modulation of vascularization28,29; and cell sheet technology allows for convenient manipulation of vascular layering30. Nevertheless, these strategies do not endow the capability of controlling the spatial patterning of the vasculature, often leading to random distribution of blood vessels within an engineered tissue construct and thus limited reproducibility. During the past few years bioprinting has emerged as a class of enabling technologies towards the solution of such a challenge, due to their unparalleled versatility of depositing complex tissue patterns at high fidelity and reproducibility in an automated or semi-automated manner31,32,33. Sacrificial bioprinting34,35,36,37,38, embedded bioprinting39,40,41, and hollow structure bioprinting/biofabrication42,43,44,45,46,47,48,49,50,51,52,53 have all demonstrated the feasibility of generating vascular or vascularized tissues.

Alternatively, a microfluidic bioprinting strategy to fabricate microfibrous scaffolds have been recently developed, where a hybrid bioink composed of alginate and gelatin methacryloyl (GelMA) was delivered through the core of a concentric printhead and a calcium chloride (CaCl2) solution was carried through the outer sheath flow of the printhead54,55. The co-extrusion of the two flows allowed for immediate physical crosslinking of the alginate component to enable microfiber formation, while subsequent photocrosslinking ensured permanent stabilization of the multi-layer microfibrous scaffold. Of note, endothelial cells encapsulated within the bioprinted microfibers were found to proliferate and migrate towards the peripheries of the microfibers assuming lumen-like structures that mimicked the vascular bed54,55. These bioprinted, endothelialized vascular beds could be subsequently populated with desired secondary cell types to further construct vascularized tissues55. This protocol thus provides a detailed procedure of such a microfluidic bioprinting strategy enabled by the concentric nozzle design, which ensures convenient fabrication of vascularized tissues for potential applications in both tissue engineering and organoid modeling.

Protocol

The neonatal rat cardiomyocytes used in this protocol were isolated from 2-day-old Sprague-Dawley rats following a well-established procedure56 approved by the Institutional Animal Care and Use Committee at the Brigham and Women's Hospital.

1. Instrumentation of the Bioprinter

  1. Insert a smaller blunt needle (e.g., 27G, 1 inch) as the core into the center of a larger blunt needle (e.g., 18G, ½ inch) as the sheath to construct the dual-layer, concentric microfluidic printhead; make sure that the core needle is protruding slightly (~1 mm) longer than the outer shell (Figure 1A). The alignment is usually adjusted manually, but if necessary spacers of proper sizes can be temporally sandwiched in between the inner/outer needles at both the tip and the barrel sides to assist concentric alignment. Seal the junction of the barrels with epoxy glue and remove the alignment spacers from the tip side when applicable.
  2. Insert another needle (23G) in the barrel of the central needle in the reverse direction.  Then generate a hole on the side of the barrel of the outer needle and insert a metal connector of matching size into the hole, followed by sealing with epoxy glue.
  3. Connect the inlets of the printhead to a dual-channel syringe pump for injection of the bioink and the crosslinking solution, individually, through two PVC tubes. Mount the extruder onto the head of a bioprinter using a plastic holder made of poly(methyl methacrylate) (PMMA).
    NOTE: Bioprinter selection depends on availability. In our case, we have successfully tested this setup on several commercially available bioprinters. However, any bioprinter that features an x-y-z motorized stage should, in principle, enable integration of this microfluidic printhead.

2. Bioprinting the Microfibrous Vascular Bed

  1. Make the bioink using a mixture of alginate (4 w/v%, low viscosity), gelatin methacryloyl (GelMA, 1-2 w/v%)57,58, and photoinitiator Irgacure 2959 (0.2 - 0.5 wt.%) dissolved in 25 mM 2-[4-(2-hydroxyethyl) piperazin-1-yl] ethane sulfonic acid (HEPES buffer, pH 7.4) containing 10 vol.% fetal bovine serum (FBS).
  2. Make a solution of 0.3-M CaCl2 in HEPES buffer containing 10 vol.% FBS as the crosslinking carrier fluid.
  3. Immediately before bioprinting, dissociate human umbilical vein endothelial cells (HUVECs) from the flasks using treatment by 0.05 w/v% trypsin for 5 - 10 min, and resuspend the cells in the bioink at a concentration of 5 - 10 × 106 cells/mL. Pipette the suspension slowly 5 to 10 times to ensure homogenous distribution.
  4. Start the injection of the bioink/crosslinking fluid using a dual-channel syringe pump at the same flow rates of 5 µL/mL. The flows can be allowed to continuously run for up to 1 min until they stabilize. Subsequently, initiate the movement of the printhead by controlling the bioprinter at a deposition speed of approximately 4 mm/s (Figure 1B). These speeds may need fine tuning with each new setup to ensure optimal bioprinting. The bioprinting process is usually conducted at room temperature (21 - 25 °C) but this temperature may be altered. The bioprinting process should allow for fast ionic gelation of the alginate component and deposition of a microfibrous scaffold (Figure 1B).
  5. After the scaffold is bioprinted, achieve chemical gelation by further photocrosslinking the GelMA component, at approximately 5 - 10 mW/cm2 of UV light (360 - 480 nm) for 20 - 30 s (Figure 1C).
  6. Following the bioprinting and crosslinking, gently rinse the scaffold with phosphate-buffered saline (PBS) to remove the excess CaCl2. Culture the HUVECs-laden microfibrous scaffold in endothelial cell growth medium (EGM) in an incubator at 37 °C and 5 vol.% CO2 for up to 16 days with medium changed at least every 2 days. Monitor the morphologies of the HUVECs under a microscope during the culture period.

3. Constructing the Vascularized Tissues

  1. Once the HUVECs have migrated to the peripheries of the microfibers in the scaffold to form the lumen-like structures (Figure 1D), retrieve the scaffold and gently place it on the surface of a hydrophobic surface (e.g., a slab of polymethylsiloxane [PDMS]). Use a piece of sterile filter paper to carefully remove all the medium from the interstitial space of the scaffold with capillary force.
  2. Immediately add a drop (approximately 20 - 40 µL) of suspension of a secondary cell type (e.g., cardiomyocytes) in medium at a density of 1 - 10 × 106 cells/mL on top of the scaffold, which should infiltrate the entire interstitial space of the scaffold (Figure 1E). Incubate such a configuration in an incubator (37 °C, 5 vol.% CO2, 95% relative humidity) for 0.5 - 2 h to allow the cells to adhere onto the individual microfibers. Monitor the droplet size over the period to ensure that no noticeable evaporation is observed.
  3. Gently wash the scaffolds by shaking in a PBS bath to remove any non-adherent cells and culture the construct in relevant medium until the desired vascularized tissue is formed.

Results

The microfluidic bioprinting strategy allows for direct extrusion bioprinting of microfibrous scaffolds using low-viscosity bioinks54,55. As illustrated in Figure 2A, a scaffold with a size of 6 × 6 × 6 mm3 containing >30 layers of microfibers could be bioprinted within 10 min. The immediate ionic crosslinking of the alginate component with CaCl2 al...

Discussion

Construction of the co-axial printhead represents a critical step towards successful microfluidic bioprinting to allow for simultaneous delivery of both the bioink from the core and the crosslinking agent from the sheath. While in this protocol an example printhead was created using a 27G needle as the core and an 18G needle as the shell, it may be readily extended to a variety of combinations using different sizes of needles. However, the alteration in the needle sizes, which results in the change in the amount of flow ...

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

The authors acknowledge the National Cancer Institute of the National Institutes of Health Pathway to Independence Award (K99CA201603).

Materials

NameCompanyCatalog NumberComments
Alginic acid sodium salt from brown algaeSigma-AldrichA0682BioReagent, plant cell culture tested, low viscosity, powder
Gelatin type A from porcine skinSigma-AldrichG2500Gel strength 300
Irgacure 2959 (2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone)Sigma-Aldrich41089698%
HEPES bufferSigma-AldrichH08871 M, pH 7.0 - 7.6, sterile-filtered, BioReagent, suitable for cell culture
Fetal bovine serum Thermo Fisher Scientific10438026Qualified, heat-inactivated, USDA-approved regions
Calcium chloride dihydrateSigma-AldrichC5080BioXtra, ≥99.0%
Phosphate buffered salineThermo Fisher Scientific10010023pH 7.4
Human umbilical vein endothelial cellsAngio-ProteomiecAP-0001Human Umbilical Vein Endothelial Cells (HUVECs)
GFP-expressing human umbilical vein endothelial cellsAngio-ProteomiecAP-0001GFPGFP-Expressing Human Umbilical Vein Endothelial Cells (GFPHUVECs)
Endothelial cell growth mediumLonzaCC-3162EGM-2 BulletKit
Dulbecco’s Modified Eagle Medium Thermo Fisher Scientific12430054High glucose, HEPES
Sylgard 184 silicone elastomer kitEllsworth Adhesives184 SIL ELAST KIT 0.5KGClear 0.5 kg Kit
UV curing lamp systemExcelitas TechnologiesOmniCure S2000Spot UV Light Curing System with Intelligent UV Sensor

References

  1. Langer, R., Vacanti, J. P. Tissue Engineering. Science. 260 (5110), 920-926 (1993).
  2. Khademhosseini, A., Vacanti, J. P., Langer, R. Progress in Tissue Engineering. Sci. Am. 300 (5), 64-71 (2009).
  3. Langer, R. Tissue Engineering: Status and Challenges. E-Biomed: J.Regen. Med. 1 (1), 5-6 (2004).
  4. Atala, A., Kasper, F. K., Mikos, A. G. Engineering Complex Tissues. Sci. Transl. Med. 4 (160), 112 (2012).
  5. Biondi, M., Ungaro, F., Quaglia, F., Netti, P. A. Controlled Drug Delivery in Tissue Engineering. Adv. Drug Del. Rev. 60 (2), 229-242 (2008).
  6. Tayalia, P., Mooney, D. J. Controlled Growth Factor Delivery for Tissue Engineering. Adv. Mater. 21 (32-33), 3269-3285 (2009).
  7. Hubbell, J. A. Biomaterials in Tissue Engineering. Nat. Biotechnol. 13 (6), 565-576 (1995).
  8. Place, E. S., Evans, N. D., Stevens, M. M. Complexity in Biomaterials for Tissue Engineering. Nat. Mater. 8 (6), 457-470 (2009).
  9. Rice, J. J., et al. Engineering the Regenerative Microenvironment with Biomaterials. Adv. Healthcare Mater. 2 (1), 57-71 (2012).
  10. Zhang, Y. S., Xia, Y. Multiple Facets for Extracellular Matrix Mimicking in Regenerative Medicine. Nanomedicine. 10 (5), 689-692 (2015).
  11. Huh, D., Hamilton, G. A., Ingber, D. E. From 3D Cell Culture to Organs-on-Chips. Trends Cell Biol. 21 (12), 745-754 (2011).
  12. Bhatia, S. N., Ingber, D. E. Microfluidic Organs-on-Chips. Nat. Biotechnol. 32 (8), 760-772 (2014).
  13. Esch, E. W., Bahinski, A., Huh, D. Organs-on-Chips at the Frontiers of Drug Discovery. Nat. Rev. Drug Discov. 14 (4), 248-260 (2015).
  14. Zhang, Y. S., Khademhosseini, A. Seeking the Right Context for Evaluating Nanomedicine: From Tissue Models in Petri Dishes to Microfluidic Organs-on-a-Chip. Nanomedicine. 10, 685-688 (2015).
  15. Zhang, C., Zhao, Z., Abdul Rahim, N. A., Van Noort, D., Yu, H. Towards a Human-on-Chip: Culturing Multiple Cell Types on a Chip with Compartmentalized Microenvironments. Lab Chip. 9 (22), 3185-3192 (2009).
  16. Moraes, C., Mehta, G., Lesher-Perez, S. C., Takayama, S. Organs-on-a-Chip: A Focus on Compartmentalized Microdevices. Ann. Biomed. Eng. 40 (6), 1211-1227 (2012).
  17. Sung, J. H., et al. Microfabricated Mammalian Organ Systems and Their Integration into Models of Whole Animals and Humans. Lab Chip. 13 (7), 1201-1212 (2013).
  18. Wikswo, J. P. The Relevance and Potential Roles of Microphysiological Systems in Biology and Medicine. Exp. Biol. Med. 239 (9), 1061-1072 (2014).
  19. Yum, K., Hong, S. G., Healy, K. E., Lee, L. P. Physiologically Relevant Organs on Chips. Biotechnol. J. 9 (1), 16-27 (2014).
  20. Nomi, M., Atala, A., Coppi, P. D., Soker, S. Principals of Neovascularization for Tissue Engineering. Mol. Aspects Med. 23 (6), 463-483 (2002).
  21. Jain, R. K., Au, P., Tam, J., Duda, D. G., Fukumura, D. Engineering Vascularized Tissue. Nat. Biotechnol. 23 (7), 821-823 (2005).
  22. Rouwkema, J., Rivron, N. C., Van Blitterswijk, C. A. Vascularization in Tissue Engineering. Trends Biotechnol. 26 (8), 434-441 (2008).
  23. Bae, H., et al. Building Vascular Networks. Sci. Transl. Med. 4 (160), 123 (2012).
  24. Rouwkema, J., Khademhosseini, A. Vascularization and Angiogenesis in Tissue Engineering: Beyond Creating Static Networks. Trends Biotechnol. 34 (9), 733-745 (2016).
  25. Perets, A., et al. Enhancing the Vascularization of Three-Dimensional Porous Alginate Scaffolds by Incorporating Controlled Release Basic Fibroblast Growth Factor Microspheres. J. Biomed. Mater. Res. A. 65 (4), 489-497 (2003).
  26. Davies, N. H., Schmidt, C., Bezuidenhout, D., Zilla, P. Sustaining Neovascularization of a Scaffold through Staged Release of Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-BB. Tissue Eng. A. 18 (1-2), 26-34 (2012).
  27. Sorrell, J. M., Baber, M. A., Caplan, A. I. Influence of Adult Mesenchymal Stem Cells on in Vitro Vascular Formation. Tissue Eng. A. 15 (7), 1751-1761 (2009).
  28. Quint, C., et al. Decellularized Tissue-Engineered Blood Vessel as an Arterial Conduit. Proct. Natl. Acad. Sci. U.S.A. 108 (22), 9214-9219 (2011).
  29. Choi, S. -. W., Zhang, Y., Macewan, M. R., Xia, Y. Neovascularization in Biodegradable Inverse Opal Scaffolds with Uniform and Precisely Controlled Pore Sizes. Adv. Healthcare Mater. 2 (1), 145-154 (2013).
  30. Sakaguchi, K., Shimizu, T., Okano, T. Construction of Three-Dimensional Vascularized Cardiac Tissue with Cell Sheet Engineering. J. Controlled Release. 205, 83-88 (2015).
  31. Zhang, Y. S., et al. 3D Bioprinting for Tissue and Organ Fabrication. Ann. Biomed. Eng. 45 (1), 148-163 (2017).
  32. Malda, J., et al. 25th Anniversary Article: Engineering Hydrogels for Biofabrication. Adv. Mater. 25 (36), 5011-5028 (2013).
  33. Murphy, S. V., Atala, A. 3d Bioprinting of Tissues and Organs. Nat. Biotechnol. 32 (8), 773-785 (2014).
  34. Miller, J. S., et al. Rapid Casting of Patterned Vascular Networks for Perfusable Engineered Three-Dimensional Tissues. Nat. Mater. 11 (9), 768-774 (2012).
  35. Bertassoni, L. E., et al. Hydrogel Bioprinted Microchannel Networks for Vascularization of Tissue Engineering Constructs. Lab Chip. 14 (13), 2202-2211 (2014).
  36. Kolesky, D. B., et al. 3d Bioprinting of Vascularized, Heterogeneous Cell-Laden Tissue Constructs. Adv. Mater. 26 (19), 3124-3130 (2014).
  37. Lee, V. K., et al. Creating Perfused Functional Vascular Channels Using 3d Bio-Printing Technology. Biomaterials. 35 (28), 8092-8102 (2014).
  38. Zhang, Y. S., et al. Bioprinted Thrombosis-on-a-Chip. Lab Chip. 16, 4097-4105 (2016).
  39. Bhattacharjee, T., et al. Writing in the Granular Gel Medium. Science Advances. 1 (8), 1500655 (2015).
  40. Highley, C. B., Rodell, C. B., Burdick, J. A. Direct 3d Printing of Shear-Thinning Hydrogels into Self-Healing Hydrogels. Adv. Mater. 27 (34), 5075-5079 (2015).
  41. Hinton, T. J., et al. Three-Dimensional Printing of Complex Biological Structures by Freeform Reversible Embedding of Suspended Hydrogels. Science Advances. 1 (9), 1500758 (2015).
  42. Jia, W., et al. Direct 3d Bioprinting of Perfusable Vascular Constructs Using a Blend Bioink. Biomaterials. 106, 58-68 (2016).
  43. Zhang, Y., et al. In Vitro Study of Directly Bioprinted Perfusable Vasculature Conduits. Biomaterials Science. 3 (1), 134-143 (2015).
  44. Gao, Q., He, Y., Fu, J. -. Z., Liu, A., Ma, L. Coaxial Nozzle-Assisted 3D Bioprinting with Built-in Microchannels for Nutrients Delivery. Biomaterials. 61, 203-215 (2015).
  45. Cornock, R., Beirne, S., Thompson, B., Wallace, G. G. Coaxial Additive Manufacture of Biomaterial Composite Scaffolds for Tissue Engineering. Biofabrication. 6 (2), 025002 (2014).
  46. Duan, B., Hockaday, L. A., Kang, K. H., Butcher, J. T. 3D Bioprinting of Heterogeneous Aortic Valve Conduits with Alginate/Gelatin Hydrogels. J. Biomed. Mater. Res. A. 101 (5), 1255-1264 (2013).
  47. Skardal, A., et al. Photocrosslinkable Hyaluronan-Gelatin Hydrogels for Two-Step Bioprinting. Tissue Eng. A. 16 (8), 2675-2685 (2010).
  48. Li, S., et al. Direct Fabrication of a Hybrid Cell/Hydrogel Construct by a Double-Nozzle Assembling Technology. J. Bioact. Compatible Polym. 24 (3), 249-265 (2009).
  49. Visser, J., et al. Biofabrication of Multi-Material Anatomically Shaped Tissue Constructs. Biofabrication. 5 (3), 035007 (2013).
  50. Boyd, D. A., Adams, A. A., Daniele, M. A., Ligler, F. S. Microfluidic Fabrication of Polymeric and Biohybrid Fibers with Predesigned Size and Shape. Journal of visualized experiments: JoVE. (83), e50958 (2014).
  51. Daniele, M. A., Adams, A. A., Naciri, J., North, S. H., Ligler, F. S. Interpenetrating Networks Based on Gelatin Methacrylamide and Peg Formed Using Concurrent Thiol Click Chemistries for Hydrogel Tissue Engineering Scaffolds. Biomaterials. 35 (6), 1845-1856 (2014).
  52. Daniele, M. A., Boyd, D. A., Adams, A. A., Ligler, F. S. Microfluidic Strategies for Design and Assembly of Microfibers and Nanofibers with Tissue Engineering and Regenerative Medicine Applications. Adv. Healthcare Mater. 4 (1), 11-28 (2015).
  53. Daniele, M. A., Radom, K., Ligler, F. S., Adams, A. A. Microfluidic Fabrication of Multiaxial Microvessels Via Hydrodynamic Shaping. RSC Advances. 4 (45), 23440-23446 (2014).
  54. Colosi, C., et al. Microfluidic Bioprinting of Heterogeneous 3D Tissue Constructs Using Low Viscosity Bioink. Adv. Mater. 28 (4), 677-684 (2015).
  55. Zhang, Y. S., et al. Bioprinting 3D Microfibrous Scaffolds for Engineering Endothelialized Myocardium and Heart-on-a-Chip. Biomaterials. 110, 45-59 (2016).
  56. Khademhosseini, A., et al. Microfluidic Patterning for Fabrication of Contractile Cardiac Organoids. Biomed. Microdevices. 9 (2), 149-157 (2007).
  57. Yue, K., et al. Synthesis, Properties, and Biomedical Applications of Gelatin Methacryloyl (GelMA) Hydrogels. Biomaterials. 73, 254-271 (2015).
  58. Loessner, D., et al. Functionalization, Preparation and Use of Cell-Laden Gelatin Methacryloyl-Based Hydrogels as Modular Tissue Culture Platforms. Nat. Protocols. 11 (4), 727-746 (2016).
  59. Aung, A., Theprungsirikul, J., Lim, H. L., Varghese, S. Chemotaxis-Driven Assembly of Endothelial Barrier in a Tumor-on-a-Chip Platform. Lab Chip. 16, 1886-1898 (2016).
  60. Shin, S. R., et al. A Bioactive Carbon Nanotube-Based Ink for Printing 2d and 3d Flexible Electronics. Adv. Mater. 28 (17), 3280-3289 (2016).
  61. Shin, S. R., et al. Aptamer-Based Microfluidic Electrochemical Biosensor for Monitoring Cell Secreted Cardiac Biomarkers. Anal. Chem. 88, 10019-10027 (2016).
  62. Zhang, Y. S., et al. Google Glass-Directed Monitoring and Control of Microfluidic Biosensors and Actuators. Sci. Rep. 6, 22237 (2016).
  63. Colosi, C., et al. Rapid Prototyping of Chitosan-Coated Alginate Scaffolds through the Use of a 3d Fiber Deposition Technique. J. Mater. Chem. B. 2 (39), 6779-6791 (2014).
  64. Zhu, W., et al. Direct 3D Bioprinting of Prevascularized Tissue Constructs with Complex Microarchitecture. Biomaterials. 124, 106-115 (2017).
  65. Yu, Y., Zhang, Y., Martin, J. A., Ozbolat, I. T. Evaluation of Cell Viability and Functionality in Vessel-Like Bioprintable Cell-Laden Tubular Channels. J. Biomech. Eng. 135 (9), 091011-091011 (2013).
  66. Zhang, Y., Yu, Y., Chen, H., Ozbolat, I. T. Characterization of Printable Cellular Micro-Fluidic Channels for Tissue Engineering. Biofabrication. 5 (2), 025004 (2013).
  67. Zhang, Y., Yu, Y., Ozbolat, I. T. Direct Bioprinting of Vessel-Like Tubular Microfluidic Channels. J. Nanotechnol. Eng. Med. 4 (2), 020902 (2013).
  68. Dolati, F., et al. In Vitro Evaluation of Carbon-Nanotube-Reinforced Bioprintable Vascular Conduits. Nanotechnology. 25 (14), 145101 (2014).
  69. Hansen, C. J., et al. High-Throughput Printing Via Microvascular Multinozzle Arrays. Adv. Mater. 25 (1), 96-102 (2013).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Microfluidic BioprintingVascularized TissuesOrganoidsVascular VatCardiac TissuesLiverSkinCancerBioprinterAlginateGelMAPhotoinitiatorHEPES BufferFBSCalcium ChlorideHUVECsDual Channel Syringe PumpCrosslinking

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Contact Us

Recommend to library

JoVE NEWSLETTERS

Research

Education

Authors

Librarians

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved